NASDAQ · Biotechnology

Skye Bioscience, Inc. Common Stock (SKYE)

$2.11 +6.03%

Add alert

36 In band Daily RSI (14) · 15 Sep 2026

Moving averages

SMA 200$6.44-67.24%

Company profile

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.

SectorHealthcare

IndustryBiotechnology

Market cap$7.86M

P/E ratioNone

EPS$-9.32

Beta2.99

Dividend yield0.00%

52-week high$4.99

52-week low$0.26

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 48 VRTX Vertex Pharmaceuticals Inc RSI 46 CRSP CRISPR Therapeutics AG RSI 44 IOVA Iovance Biotherapeutics Inc RSI 69 RXRX Recursion Pharmaceuticals Inc - Class A RSI 53 MRNA Moderna Inc RSI 62 VKTX Viking Therapeutics Inc RSI 40 SRPT Sarepta Therapeutics Inc RSI 55 EDIT Editas Medicine Inc RSI 43 NVAX Novavax Inc RSI 57

Free forever

RSI alerts for SKYE

Get an email the moment Skye Bioscience, Inc. Common Stock crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 31 August 2026 at 3:49 AM EDT